OPINION REVIEW

1. Non-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence?

REVIEW

1. Liver-side of inflammatory bowel diseases: Hepatobiliary and druginduced disorders
2. Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases
3. Genotype E: The neglected genotype of hepatitis B virus

MINIREVIEWS

1. One stop shop approach for the diagnosis of liver hemangioma
2. Liver function in COVID-19 infection
3. Potential role of noninvasive biomarkers during liver fibrosis
4. Imaging evaluation of the liver in oncology patients: A comparison of techniques
5. Liver manifestations and complications in inflammatory bowel disease: A review
6. Dengue hemorrhagic fever and the liver
7. Artificial Intelligence in hepatology, liver surgery and transplantation: Emerging applications and frontiers of research
8. De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation
9. Liver dysfunction as a cytokine storm manifestation and prognostic factor for severe COVID-19
10. COVID-19 and the liver: A brief and core review
11. Newer variants of progressive familial intrahepatic cholestasis
12. Deep learning in hepatocellular carcinoma: Current status and future perspectives

ORIGINAL ARTICLE

1. Gut dysbiosis and systemic inflammation promote cardiomyocyte abnormalities in an experimental model of steatohepatitis
2. Leukocyte cell-derived chemotaxin-2 and fibroblast growth factor 21 in alcohol-induced liver cirrhosis
3. Biliary complications in recipients of living donor liver transplantation: A single-centre study
4. Liver function tests and metabolic-associated fatty liver disease:Changes in upper normal limits, does it really matter?
5. Use of oral vancomycin in children with autoimmune liver disease: A single centre experience
6. Trends of alcoholic liver cirrhosis readmissions from 2010 to 2018:Rates and healthcare burden associated with readmissions
7. New stem cell autophagy surrogate diagnostic biomarkers in earlystage hepatocellular carcinoma in Egypt: A pilot study
8. Determination of “indeterminate score” measurements in lean nonalcoholic fatty liver disease patients from western Saudi Arabia
9. Managing liver transplantation during the COVID-19 pandemic: A survey among transplant centers in the Southeast United States
10. Accuracy of virtual chromoendoscopy in differentiating gastric antral vascular ectasia from portal hypertensive gastropathy: A proof of concept study
11. Non-alcoholic steatohepatitis in liver transplant recipients diagnosed by serum cytokeratin 18 and transient elastography: A prospective study

CASE REPORT

1. Rare primary mature teratoma of the liver: A case report